JP2024532131A - 銅代謝関連疾患又は障害を治療する方法 - Google Patents

銅代謝関連疾患又は障害を治療する方法 Download PDF

Info

Publication number
JP2024532131A
JP2024532131A JP2024509042A JP2024509042A JP2024532131A JP 2024532131 A JP2024532131 A JP 2024532131A JP 2024509042 A JP2024509042 A JP 2024509042A JP 2024509042 A JP2024509042 A JP 2024509042A JP 2024532131 A JP2024532131 A JP 2024532131A
Authority
JP
Japan
Prior art keywords
subject
copper
tetrathiomolybdate
weeks
ttm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024509042A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024532131A5 (https=
Inventor
ブライアン メルツァー，
ユージーン スコット スウェンソン，
ウェイ－ジアン パン，
スコット エドワード モズリー，
ライアン ペルト，
アダム キックアロ，
Original Assignee
アレクシオン ファーマシューティカルズ， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アレクシオン ファーマシューティカルズ， インコーポレイテッド filed Critical アレクシオン ファーマシューティカルズ， インコーポレイテッド
Publication of JP2024532131A publication Critical patent/JP2024532131A/ja
Publication of JP2024532131A5 publication Critical patent/JP2024532131A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2024509042A 2021-08-17 2022-08-17 銅代謝関連疾患又は障害を治療する方法 Pending JP2024532131A (ja)

Applications Claiming Priority (25)

Application Number Priority Date Filing Date Title
US202163234176P 2021-08-17 2021-08-17
US63/234,176 2021-08-17
US202163235098P 2021-08-19 2021-08-19
US63/235,098 2021-08-19
US202163237120P 2021-08-25 2021-08-25
US202163237089P 2021-08-25 2021-08-25
US63/237,089 2021-08-25
US63/237,120 2021-08-25
US202163237506P 2021-08-26 2021-08-26
US63/237,506 2021-08-26
US202163270421P 2021-10-21 2021-10-21
US63/270,421 2021-10-21
US202163281994P 2021-11-22 2021-11-22
US63/281,994 2021-11-22
US202163290599P 2021-12-16 2021-12-16
US63/290,599 2021-12-16
US202163294715P 2021-12-29 2021-12-29
US63/294,715 2021-12-29
US202263322155P 2022-03-21 2022-03-21
US63/322,155 2022-03-21
US202263339307P 2022-05-06 2022-05-06
US63/339,307 2022-05-06
US202263353790P 2022-06-20 2022-06-20
US63/353,790 2022-06-20
PCT/US2022/040663 WO2023023199A1 (en) 2021-08-17 2022-08-17 Methods of treating copper metabolism-associated diseases or disorders

Publications (2)

Publication Number Publication Date
JP2024532131A true JP2024532131A (ja) 2024-09-05
JP2024532131A5 JP2024532131A5 (https=) 2025-08-26

Family

ID=83271296

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024509042A Pending JP2024532131A (ja) 2021-08-17 2022-08-17 銅代謝関連疾患又は障害を治療する方法

Country Status (5)

Country Link
US (1) US20250082674A1 (https=)
EP (1) EP4387631A1 (https=)
JP (1) JP2024532131A (https=)
CA (1) CA3228221A1 (https=)
WO (1) WO2023023199A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023038909A1 (en) * 2021-09-07 2023-03-16 Alexion Pharmaceuticals, Inc. Methods of treating copper metabolism-associated diseases or disorders
KR20240159714A (ko) * 2023-04-27 2024-11-06 국립해양생물자원관 다중구리 산화효소 활성 도메인의 개량 펩타이드를 포함하는 구리대사 관련 신경계 질환의 예방 또는 치료용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11419832B2 (en) * 2017-12-04 2022-08-23 Alexion Pharmaceuticals, Inc. Bis-choline tetrathiomolybdate for treating Wilson Disease
MX2020006284A (es) * 2017-12-04 2021-04-12 Alexion Pharma Int Operations Unlimited Company Tetratiomolibdato de bis-colina para tratar la enfermedad de wilson.
US20220334135A1 (en) 2019-09-12 2022-10-20 Alexion Pharmaceuticals, Inc. Methods of measuring copper concentration in biological samples
US20220387370A1 (en) * 2019-11-21 2022-12-08 Alexion Pharmaceuticals, Inc. Methods of reducing neurological damage in wilson disease patients
EP4243806A1 (en) * 2020-11-13 2023-09-20 Alexion Pharmaceuticals, Inc. Methods of treating copper metabolism-associated diseases or disorders
WO2023038909A1 (en) * 2021-09-07 2023-03-16 Alexion Pharmaceuticals, Inc. Methods of treating copper metabolism-associated diseases or disorders

Also Published As

Publication number Publication date
EP4387631A1 (en) 2024-06-26
US20250082674A1 (en) 2025-03-13
WO2023023199A1 (en) 2023-02-23
CA3228221A1 (en) 2023-02-23

Similar Documents

Publication Publication Date Title
US12233088B2 (en) Bis-choline tetrathiomolybdate for treating Wilson Disease
CN103974619A (zh) 治疗法布里病的给药方案
US11419832B2 (en) Bis-choline tetrathiomolybdate for treating Wilson Disease
JP2024532131A (ja) 銅代謝関連疾患又は障害を治療する方法
JP2023549814A (ja) 銅代謝関連疾患又は障害を治療する方法
Chao et al. Diflunisal versus tafamidis on neuropathy and cardiomyopathy in hereditary transthyretin amyloidosis
JP2024534936A (ja) 銅代謝関連疾患又は障害を治療する方法
JP2026503721A (ja) 銅代謝関連疾患又は障害（ウィルソン病）の治療における使用のためのテトラチオモリブデン酸
CN117835989A (zh) 治疗铜代谢相关疾病或障碍的方法
CA3084100C (en) Bis-choline tetrathiomolybdate for treating wilson disease
Ballester et al. A randomized, open-label, Phase 2a study to assess the safety, pharmacodynamics, and pharmacokinetics of YAQ007 versus rifaximin in cirrhosis
TW202308600A (zh) 未與銅藍蛋白結合之銅的濃度監測

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250818

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250818